English HomeTech NewsApple NewsArabic Home
Productivity

Clinical trial shows gene editing works for β-Thalassaemia, too

Ars Technica • Thu, 09 Apr 2026

Clinical trial shows gene editing works for β-Thalassaemia, too

Improved gene editing process reactivates the fetal version of a hemoglobin gene.

What happened?

Improved gene editing process reactivates the fetal version of a hemoglobin gene.

Story details

Improved gene editing process reactivates the fetal version of a hemoglobin gene.

Why it matters

This story helps build a stronger internal English tech archive around Productivity, giving search visitors more reasons to keep browsing the site instead of bouncing after a single headline.

Original source

https://arstechnica.com/science/2026/04/clinical-trial-shows-gene-editing-works-for-%ce%b2-thalassaemia-too/